Buradasınız

Canlı Böbrek Nakli Verici Adaylarının Elenme Nedenleri: Tek Merkez Deneyimi

Exclusion Reasons of Living Kidney Donor Candidates: A Single-Center Experience

Journal Name:

Publication Year:

DOI: 
10.5262/tndt.2014.1002.06
Abstract (2. Language): 
OBJECTIVE: Due to severe organ shortage, living kidney donors are important choices for transplantation. In Muslim countries, such as Turkey, living kidney donors are the main source of donor pool. In the literature, reasons for living donor exclusion are reported from several countries. However, there is no published study that focused on exclusion reasons of donor candidates in Turkey where living kidney transplantation rate is 73.4%. The goal of this retrospective study was to examine the exclusion reasons for donation among living kidney donor candidates at a single center in Turkey. MATERIAL and METHODS : A total 538 adults were evaluated as a living kidney donor candidate between December 1988 and January 2012. Evaluation outcome, exclusion reasons and demographic data were examined from electronic file system and immunology laboratory records. RESUL TS: In this period 451 kidney transplantations (38.6% cadaveric, 61.4% living donor) was performed. Overall 261 (48.5%) donor candidates who underwent evaluation could not donate. We were able to find the precise cause of exclusion of 86 donors (33%). Among excluded donor candidates the most common exclusion reason was medical causes (64%) such as diabetes mellitus, low glomerular filtration rate and hypertension. CONCLUS ION: Our study suggests that medical causes are significant exclusion reasons for living kidney donation at our center.
Abstract (Original Language): 
AMAÇ: Organ bağışının istenilen düzeyde olmaması nedeni ile canlı böbrek nakli verici adayları, böbrek nakli için önemli kaynak oluşturmaktadır. Türkiye gibi Müslüman ülkelerde bu durum daha da belirgindir. Literatürde çeşitli ülkelerden böbrek nakli için canlı verici adaylarının elenme nedenlerini bildiren çalışmalar mevcuttur. Canlı böbrek nakli oranının %73,4 olduğu ülkemizden ise verici adaylarının elenme nedenlerine yönelik bir çalışma bulunmamaktadır. Çalışmamızın amacı, retrospektif olarak canlı böbrek nakli verici adaylarının elenme nedenlerini değerlendirmektir. GEREÇ ve YÖNTEMLER: Çalışmaya Aralık 1988 ve Ocak 2012 tarihleri arasında merkezimize böbrek nakli verici adayı olarak başvurmuş 538 kişi dahil edilmiştir. Elektronik dosyaların ve immünoloji laboratuvar kayıtlarının taranması ile adaylık değerlendirme sonuçları, elenme nedenleri ve demografik bilgileri değerlendirilmiştir. BUL GUL AR: Çalışma süresince merkezimizde 451 böbrek nakli (%38,6 kadaverik, %61,4 canlı) gerçekleştirilmiştir. Adaylardan 261 (%48,5) kişi verici olamamıştır. Seksen altı (%33) adayın kesin elenme nedenine ulaşabilmiştir. Diyabetes mellitus, düşük glomerüler filtrasyon hızı ve hipertansiyon gibi medikal nedenler en önemli (%64) elenme nedeni olarak belirlenmiştir. SONU Ç: Merkezimize başvuran canlı böbrek nakli verici adaylarının, en sık elenme nedeni medikal nedenler olarak tespit edilmiştir.
112
117

REFERENCES

References: 

1. Oliver M, Woywodt A, Ahmed A, Saif I: Organ donation,
transplantation and religion. Nephrol Dial Transplant 2011; 26: 437-
444
2. Freitas MC: Kidney transplantation in the US: An analysis of the
OPTN/UNOS registry. Clin Transpl 2011: 1-163. Einollahi B: Cadaveric kidney transplantation in Iran: Behind the
Middle Eastern countries? Iran J Kidney Dis 2008; 2: 55-56
4. Kidney Transplantation. In: Suleymanlar G, Altiparmak MR,
Seyahi N, Trabulus S (eds), Registry of the Nephrology, Dialysis
and Transplantation: Registry 2011. İstanbul: Pasifik Reklam ve
Tanıtım, 2012; 28-35
5. Delmonico F: A Report of the Amsterdam Forum On the Care of the
Live Kidney Donor: Data and medical guidelines. Transplantation
2005; 79: S53-66
6. Pham PC, Wilkinson AH, Pham PT: Evaluation of the potential
living kidney donor. Am J Kidney Dis 2007; 50: 1043-1051
7. Sachdeva M, Bhaskaran M, Molmenti EP, Dalton D, Mattana J:
Approach to the pretransplant evaluation of the living kidney donor.
J Transplant 2011; 2011: 245738
8. Kher A, Mandelbrot DA: The living kidney donor evaluation: Focus
on renal issues. Clin J Am Soc Nephrol 2012; 7: 366-371
9. Lapasia JB, Kong SY, Busque S, Scandling JD, Chertow GM,
Tan JC: Living donor evaluation and exclusion: The Stanford
experience. Clin Transplant 2011; 25: 697-704
10. Zhao WY, Zhang L, Han S, Zhu YH, Wang LM, Zhou MS, Zeng L:
Evaluation of living related kidney donors in China: Policies and
practices in a transplant center. Clin Transplant 2010; 24: E158-162
11. Gabolde M, Herve C, Moulin AM: Evaluation, selection, and
follow-up of live kidney donors: A review of current practice in
French renal transplant centres. Nephrol Dial Transplant 2001; 16:
2048-2052
12. Norman SP, Song PX, Hu Y, Ojo AO: Transition from donor
candidates to live kidney donors: The impact of race and undiagnosed
medical disease states. Clin Transplant 2011; 25: 136-145
13. Hidalgo G, Tejani C, Clayton R, Clayton R, Clements P, Distant
D, Vyas S, Baqi N, Singh A: Factors limiting the rate of livingrelated
kidney donation to children in an inner city setting. Pediatr
Transplant 2001; 5: 419-424
14. Okamoto M, Suzuki T, Fujiki M, Nobori S, Ushigome H, Sakamoto
S, Yoshimura N: The consequences for live kidney donors with
preexisting glucose intolerance without diabetic complication:
Analysis at a single Japanese center. Transplantation 2010; 89:
1391-1395
15. Guvence N, Oskay K, Ayli D: The assessment of long-term clinic
and laboratory data of living related kidney donors. Transplant Proc
2012; 44: 1614-1617
16. Boudville N, Prasad GV, Knoll G, Muirhead N, Thiessen-Philbrook
H, Yang RC, Rosas-Arellano MP, Housawi A, Garg AX: Metaanalysis:
Risk for hypertension in living kidney donors. Ann Intern
Med 2006; 145: 185-196
17. Textor SC, Taler SJ, Driscoll N, Larson TS, Gloor J, Griffin M,
Cosio F, Schwab T, Prieto M, Nyberg S, Ishitani M, Stegall M:
Blood pressure and renal function after kidney donation from
hypertensive living donors. Transplantation 2004; 78: 276-282
18. Tent H, Sanders JS, Rook M, Hofker HS, Ploeg RJ, Navis G,
Van der Heide JJ: Effects of preexistent hypertension on blood
pressure and residual renal function after donor nephrectomy.
Transplantation 2012; 93: 412-41719. Santos L, Macario F, Alves R, Mota A, Campos M: Risks of living
donor nephrectomy. Transplant Proc 2010; 42: 1484-1486
20. Reeves-Daniel A, Adams PL, Daniel K, Assimos D, Westcott C,
Alcorn SG, Rogers J, Farney AC, Stratta RJ, Hartmann EL: Impact
of race and gender on live kidney donation. Clin Transplant 2009;
23: 39-46
21. UNOS: The Organ Procurement and Transplantation Network.
United Network of Organ Sharing (UNOS). 2010
22. Ersoy C, Imamoglu S, Tuncel E, Erturk E, Ercan I: Comparison
of the factors that influence obesity prevalence in three district
municipalities of the same city with different socioeconomical
status: A survey analysis in an urban Turkish population. Prev Med
2005; 40: 181-188
23. Caliskan Y, Yildiz A: Evaluation of the medically complex living
kidney donor. J Transplant 2012; 2012: 45047124. Arunachalam C, Garrues M, Biggins F, Woywodt A, Ahmed A:
Assessment of living kidney donors and adherence to national live
donor guidelines in the UK. Nephrol Dial Transplant 2013; 28:
1952-1960
25. Hourmant M, Lerat L, Karam G: Donation from old living donors:
How safe is it? Nephrol Dial Transplant 2013; 28: 2010-2014
26. Iordanous Y, Seymour N, Young A, Johnson J, Iansavichus AV,
Cuerden MS, Gill JS, Poggio E, Garg AX: Recipient outcomes for
expanded criteria living kidney donors: The disconnect between
current evidence and practice. Am J Transplant 2009; 9: 1558-1573
27. Young A, Kim SJ, Speechley MR, Huang A, Knoll GA, Prasad
GV, Treleaven D, Diamant, M, Garg AX: Accepting kidneys from
older living donors: Impact on transplant recipient outcomes. Am J
Transplant 2011; 11: 743-750

Thank you for copying data from http://www.arastirmax.com